Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06123988 · ClinicalTrials.gov registry record · NA
Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer
A NA study of HER2-positive Breast Cancer and Advanced Breast Cancer, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 260
- Enrollment target
- 3
- Study locations
NCT06123988 is a NA study of HER2-positive Breast Cancer and Advanced Breast Cancer that is actively recruiting participants, run by University of Miami. The registered enrollment target is 260 participants, above the 235-participant average among 54 other HER2-positive Breast Cancer trials with a reported enrollment target (11% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT06123988, a NA study of HER2-positive Breast Cancer and Advanced Breast Cancer, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to test if four different programs (prolonged overnighting fasting alone, exercise alone, a combination of prolonged overnight fasting and exercise, or general health education sessions alone) can reduce fatigue in women with advanced or metastatic breast cancer who are receiving a medication called a cyclin-dependent kinases-4 and 6 (CDK4/6) inhibitor (e.g., palbociclib, ribociclib, or abemaciclib), with or without HER2-directed therapy (e.g., trastuzumab ± pertuzumab), or in combination with both a CDK4/6 inhibitor and a PI3K inhibitor, within the past 90 days.
Conditions Studied
Interventions
- BEHAVIORAL Prolonged Overnight Fasting
- BEHAVIORAL Moderate-Intensity Exercise
- BEHAVIORAL General Health Education Sessions
Study Locations (3)
Arizona
- Arizona State University - Phoenix
Florida
- University of Miami - Miami
Massachusetts
- Dana-Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2024-09-09 |
| Est. Completion | 2029-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06123988
The ClinicalTrials.gov registry entry for NCT06123988 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 235-participant average among 54 other HER2-positive Breast Cancer trials with a reported enrollment target (11% higher). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HER2-positive Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Prolonged Overnight Fasting is the first listed.
NCT06123988 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06123988 about?
NCT06123988 is a clinical study titled "Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer". The purpose of this study is to test if four different programs (prolonged overnighting fasting alone, exercise alone, a combination of prolonged overnight fasting and exercise, or general health education sessions alone) can reduce fatigue in women with advanced or metastatic breast cancer who are ...
What is the current status of trial NCT06123988?
This trial is currently recruiting. It is a NA study. The enrollment target is 260 participants. The study started on 2024-09-09. Estimated completion is 2029-09-30.
What conditions does trial NCT06123988 study?
This clinical trial studies the following conditions: HER2-positive Breast Cancer, Advanced Breast Cancer.
What interventions are being tested in trial NCT06123988?
The interventions under investigation include: Prolonged Overnight Fasting (BEHAVIORAL), Moderate-Intensity Exercise (BEHAVIORAL), General Health Education Sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT06123988?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06123988 being conducted?
This trial has 3 study locations across Arizona, Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HER2-positive Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NearWave Optical Molecular Monitoring
RECRUITING · NA
-
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
RECRUITING · NA
-
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
ACTIVE NOT RECRUITING · NA
-
Omission of Radiation in Patients With Her-2 Positive Breast Cancer
ACTIVE NOT RECRUITING · NA
-
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
RECRUITING · Phase 2
-
TRUDI: TDXD+Durva in HER2+/Low IBC
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.